Validation of Recombinant Heparan Sulphate Reagents for CNS Repair
Therapies that target the multicellular pathology of central nervous system (CNS) disease/injury are urgently required. Modified non-anticoagulant heparins mimic the heparan sulphate (HS) glycan family and have been proposed as therapeutics for CNS repair since they are effective regulators of numer...
| Published in: | Biology |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-7737/12/3/407 |
